Hopelessness, Not Just Cannabis, Is What Keeps First-Episode Psychosis From Lifting

Someone comes out of a first psychotic break tied to heavy cannabis use, the acute symptoms fade within weeks the way they usually do, and everyone — patient, family, sometimes the discharging psychiatrist — assumes the worst is over because the drug that “caused it” is gone from their system. A new 24-month study out of three psychiatric centers in Northern Italy, led by Valerio Ricci and colleagues in the journal Addictive Behaviors, says that assumption is the mistake.

The mood a person is in after the break predicts their recovery more than the drug does.

The study followed 72 young adults (mostly men, ages 18–35) through what clinicians call cannabis-induced first-episode psychosis — a first psychotic episode (a break involving hallucinations, delusions, or disorganized thinking) that emerges during or shortly after heavy cannabis use, tracked forward in time from the start (a prospective design, as opposed to reconstructing someone’s history after the fact) across four checkpoints: baseline, 6 months, 12 months, and 24 months. Depression and hopelessness — not cannabis use disorder (a pattern of use that keeps happening despite clear harm) by itself — independently predicted how severe psychotic symptoms stayed over that two-year window, according to the same Ricci et al. analysis. Depression and hopelessness accounted for 31% and 35%, respectively, of the link between continued cannabis use and lingering psychotic symptoms — a partial mediation, meaning mood explains a real chunk of why use tracks with worse outcomes, not the whole story.

This maps onto something familiar to anyone who has used cannabis to blunt a bad mental state rather than to get high recreationally: heavy use often starts as self-medication against exactly this kind of hopelessness, a way to go numb when nothing feels like it’s going anywhere. The self-medication logic is coherent in the short term. What this study shows is where it breaks — over 60% of participants kept using cannabis during follow-up, and continued use fed the depression and hopelessness rather than relieving them, and that combination of high hopelessness, clinically significant depression, and continued use carried a relapse risk more than four times higher (HR 4.32) than for people without that combination. Antidepressants helped the depression piece for roughly 38% of patients who took them; they did essentially nothing for the hopelessness itself.

The honest limits here matter as much as the finding: 72 people, three sites in one country, a population that had already experienced a diagnosable psychotic break — this says nothing about the much larger group of people who use cannabis heavily and never have one. It is not a study about whether cannabis “causes” psychosis in general, and treating it as reefer-madness proof would misread it as badly as treating it as no big deal would. What it does show, inside its own population, is that hopelessness is a treatable target that current relapse-prevention plans often skip past on the way to just tracking use. For anyone in science and medicine reporting on cannabinoids, the story isn’t the plant. It’s the mood nobody screened for.